You are here
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
Media Type:
Document:
Published Date:
Monday, September 10, 2012
- Home
- About Us
- Research
- PEPFAR
- Emerging Infections
- International Sites
- News
- Media Room
- Study examins long-term adverse health effects of Ebola survivors
- RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
- Early HIV Infection Study Offers Insight Into the Initial Stages of HIV Infection
- RV144 10th Anniversary
- RV144 10th Anniversary
- Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic In Africa
- Zika Vaccine Development
- MHRP in the News
- Newsletters
- Fact Sheets
- $6.3 M Awarded for the Production of an HIV-1 Subtype C gp145 Env Candidate Vaccine Developed by MHRP Scientists
- 2010 International AIDS Conference, Vienna, Austria
- 2010 International Military HIV/AIDS Conference
- 2010 MHRP World Aids Day Activities
- A Day in the Life of a Nigerian Study Nurse
- A Foucus on Acute Infection Studies
- A Foucus on Acute Infection Studies
- A Trip to Koome Island
- A Vaccine to Prevent Zika Infection in Humans is Feasible
- AFRIMS Celebrates 50 Years of Medical Research In Thailand
- AIDS 2012
- AIDS Vaccine 2012
- AIDS Vaccine Conference 2009
- AIDS Vaccine Researchers Gather in Thailand for Annual Vaccine Conference
- Ambassador Goosby Site Visit
- At the Frontlines of an Epidemic: Combating Ebola in Liberia
- At the Frontlines of an Epidemic: Combating Ebola in Liberia
- Bioethics Commission Urges US to Adopt Ethical Approach to Ebola & Health Preparedness
- Biomarkers of Disease Progression Appear to Differ in Sub-Saharan Population
- Bringing Health Services to the People
- Bringing Health Services to the People
- Building on RV144: HIV Vaccien Trial Launches in South Africa
- COL Kim Provides Commentary for Series, "30 years in 30 weeks"
- CROI 2012 Wrap Up
- CROI 2013 Wrap-up
- Capt. Darrell Singer Recognized for His Exceptional Contributions to PEPFAR
- Caring for the Children Left Behind by HIV
- Clinical center expands and enhances care in Mbeya, Tanzania
- Collaborative Efforts to Combat Malaria in Tanzania
- Community Events Promote HIV Vaccine Awareness in Kenya
- Community Relations: Uganda Participates in Kampala Marathon
- Community and Media Events Promote Vaccine Importance in Uganda
- Comprehensive New Framework to Speed and Enhance HIV Research
- Congressional Delegation Visits MHRP Site in Kericho, Kenya
- Contraception Use During HIV Vaccine Trial
- DoD Leadership Visits MHRP's Nigeria Research Site
- Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
- Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
- Duke and MHRP Win Award for Best Academic Research Team
- Early Infant Diagnosis and Rapid Treatment Key to Meeting UNAIDS 90-90-90 Targets
- Early Study Shows MHRP Vaccine Candidate, MVA-CMDR, Safe and Immunogenic
- Early antiretroviral therapy dramatically reduces HIV DNA set point
- Early-Capture HIV Study Allows for Characterization of Acute Infection Period
- Family day at an HIV clinic in Tanzania
- Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
- Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
- HIV Vaccine Awareness Day 2019
- MHRP Researcher Dr. Morgane Rolland on the Importance of Viral Genetics
- MHRP Scientists and Collaborators Presenting at CROI 2019
- MHRP Scientists and Collaborators Presenting at IAS 2019
- MHRP Scientists and Collaborators Presenting at Keystone Symposia 2019
- MHRP's Top Highlights of 2019
- New Sequencing Study Provides Insight into HIV Vaccine Protection
- New study reveals how specialized antimicrobial human T cells responds in acute HIV infection
- Three Neutralizing Antibody Lineages Identified from an HIV-1-Infected Individual
- US Army and partners to launch HIV vaccine efficacy trial in the Americas and Europe
- World AIDS Day Event Highlights DoD Contributions to Fight the HIV Pandemic
- ‘This Is What It Means to Be Empowered’
- Announcing Dr. Sandhya Vasan as MHRP's Associate Director for HIV Vaccine Research
- Army-developed Zika Vaccine Induces Strong Immune Response in Three Phase 1 Studies
- Biomarker Signatures in Acute HIV Infection Associate with ViralDynamics and Reservoir Size
- Characterization of T Cells Infected with Simian Immunodeficiency Virus Reveals Host-pathogen Interactions
- DREAMS Work in Mbeya Provides a Path Out of Prostitution
- Dr. Robert Gramzinski Named as New Director of MHRP
- Experimental Vaccine Blocks Effects of Heroin in Mice
- HIV Viral Load Rebounds Rapidly After Treatment Interruption in Individuals Who Begin ART During Fiebig I
- Landmark Acute HIV Infection Cohort Study Concludes
- MHRP Scientists and Collaborators Presenting at AIDS 2018
- MHRP Scientists and Collaborators Presenting at CROI 2018
- MHRP Scientists and Collaborators at the ASTMH Annual Meeting
- MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2018
- MHRP at the 2018 Military Health System Research Symposium
- Navigating the Path to an HIV Vaccine
- New HIV Cohort Study Opens In Germany
- RNA Signatures of Natural Killer Immune Cells Suggest Increased Activity Following HIV Vaccination
- Social Science Research Involving MHRP Acute HIV Infection Cohort Seeks to Understand Volunteers' Perspectives in Treatment Interruption Studies
- Study Links Gut-Homing Protein Levels With HIV Infection Risk, Disease Progression
- Study of Severe Infectious Diseases Enrolls 100th Volunteers
- World AIDS Day 2017
- World AIDS Day 2018
- Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa
- Col. Nelson Michael Selected as One of Vice Motherboard’s ‘Humans of the Year’
- Diagnosis of Acute HIV Infection and Immediate Treatment Reduces Transmission by 89% in Thai Cohort
- Dr. Carl Alving Inducted as National Academy of Inventors Fellow
- Dr. Lydie Trautmann Awarded R01 Grant from National Institute of Mental Health
- Dual-use Heroin Vaccine Elicits Immune Response in Mice
- Experts identify challenges to fast-track development of Zika vaccine
- First Public Meeting of Cross-Sector HIV Cure Project
- Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine
- Initiating ART During Acute HIV Infection Affects Trajectory of Viral Load
- Insight into Acute HIV Infection
- Investigational HIV Therapeutic Vaccine Approach Helps Control SIV in Preclinical Studies
- Joint West Africa Research Group Begins Infectious Disease Surveillance Study in Nigeria
- Koome Island Demonstration Farm Helps Support Women and Families
- Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial
- MHRP Researchers and Collaborators Presenting at CROI 2017
- MHRP Welcomes Dr. M. Gordon Joyce, Chief of New Structural Biology Lab Section
- MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2016
- MHRP and Collaborators at the 9th IAS Conference on HIV Science
- MHRP scientists and collaborators detect declining trend in transmitted drug resistance in acute HIV infection cohort
- New MHRP PEPFAR-funded study to examine malaria and TB HIV co-infection in Kenyan Defence Forces
- New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
- New Study Provides Clues to Early T Cell Immune Responses in Acute HIV Infection
- Nigeria Biopreparedness Initiative Launches with Laboratory Training and Site Assessment
- Nigeria Study Identifies Potential Cohorts for HIV Vaccine Development
- U.S. Officials Visit with Participants in DREAMS Program
- World AIDS Day 2016: Reinvigorating the Field
- First-in-Human Phase 1 Clinical Trial of MERS Vaccine Begins
- Fitness training and events help increase HIV prevention awareness in Kenya
- Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
- Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
- Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
- Future of HIV Cure Research Points to Combination Approach
- HIV Infant Tracking System (HITSystem) Improves Early Infant Diagnosis Outcomes for HIV-Exposed Infants in Tanzania
- HIV Prevention, Care and Treatment Open House Draws Thousands to Tanzania's Southern Highlands
- HIV Vaccine Awareness Day 2009
- HIV Vaccine Awareness Day 2010
- HIV Vaccine Awareness Day 2011
- HIV Vaccine Awareness Day 2011 Activities
- HIV Vaccine Awareness Day: Building on the Success of RV144
- HIV Vaccine Development and the US Military
- HIV Vaccine Development and the US Military
- HIV Vaccine Research Center of Excellence to Open at AFRIMS
- HIV-1 Immune Evasion Mutations Could Impact Future Vaccine Efficacy
- How the Military is Engaged in the Battle Against Malaria
- How the Military is Engaged in the Battle Against Malaria
- Human Clinical Trial of DNA-MVA HIV Vaccine Candidate Begins
- Human Clinical Trial of a New DNA-MVA Vaccine Candidate Begins in Africa
- Human Genetic Studies Underscore Similarities Among East African Populations
- Humanized DRAG Mouse Model Holds Promise For Pre-Clinical Testing of Candidate HIV Vaccines
- IRIS Study Opens in Kericho, Kenya
- Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya
- In Memory of Sen. Daniel K. Inouye
- In Memory of our Nigerian Colleagues
- In South Africa, RV144 HIV Vaccine Regimen Induces Immune Responses Similiar to Those Seen in Thailand
- In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
- In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
- Infection with Multiple HIV-1 Variants Leads to Poorer Clinical Outcomes
- Initiation of ART during Acute HIV Infection Leads to High Rate of Non-Reactive HIV Serology
- Innovative "Moonlight" HIV Counseling and Testing
- Interview with Ambassador Goosby, U.S. Global AIDS Coordinator
- Joint West Africa Research Group to Foster Biopreparedness
- Joint West Africa research Group Completes First Training in Nigeria
- Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
- Laboratory Training Program Brings Together MHRP, Nigerian Military and the U.S. Public Health Service
- Lancet Article Explores Efficacy Variables in RV144
- Large Multinational HIV Cohort Study Begins in Africa
- Long-term Adverse Health Effects of Ebola Survivors Examined in New Lancet ID Paper
- MHRP Collaborates with Maryland's Institute of Human Virology on Promising HIV/AIDS Vaccine Candidate
- MHRP Community Engagement Meeting held in Uganda
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Deputy Col. Jerome Kim Receives Award for Research Excellence
- MHRP Diagnostics: A Unique Capability within the DoD
- MHRP Diagnostics: A Unique Capability within the DoD
- MHRP Director receives the Hero of Military Medicine Award for the U.S. Army
- MHRP Kenya Country Director Receives Prestigious Military Civilian Award
- MHRP Launches New Quarterly Newsletter
- MHRP Leadership Meets with the President of Tanzania
- MHRP Marks HIV Vaccine Awareness Day
- MHRP Named a Clinical Trials Unit for NIH HIV/AIDS Clinical Trials Networks
- MHRP Partners with Tanzanian People's Defense Forces to Open HIV Counseling and Testing Center
- MHRP Profiles
- MHRP Profiles
- MHRP Profiles: Ebola Vaccine Trial Participant
- MHRP Researcher Receives HIV Prevention Research Advocacy Fellowship
- MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
- MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
- MHRP Researchers find Host Genetics Played a Role in RV144 Protection
- MHRP Researchers find Host Genetics Played a Role in RV144 Protection
- MHRP Scientist Discusses WHO Ebola Collaboration
- MHRP Scientist Wins 2012 NIDA Avant-Garde Award for Combination Anti-Heroin/HIV Vaccine
- MHRP Scientists Take Part in AIDS Vaccine 2010 Conference in Atlanta
- MHRP Scientists and Collaborators Presenting at AIDS 2016
- MHRP Scientists and Collaborators Presenting at CROI 2016
- MHRP Welcomes Dr. Hendrik Streeck
- MHRP Welcomes Dr. Jintanat Ananworanich as Associate Director for Therapeutics Research
- MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
- MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
- MHRP and Collaborators Presenting at Keystone Symposia HIV Vaccine and HIV Persistence Meetings
- MHRP and Colleagues Featured in Special JAIDS Supplement
- MHRP at AIDS Vaccine 2013
- MHRP at CROI 2014
- MHRP at CROI 2014
- MHRP at HIV Research for Prevenetion (R4P) 2014
- MHRP at HIV Research for Prevenetion (R4P) 2014
- MHRP in the News: September 2011
- MHRP selected by the AIDS Clinical Trials Group (ACTG) as a Clinical Trials Unit
- MHRP's Administrative Offices Have Moved
- MUWRP Celebrates Ten Years of Progress
- MUWRP Provides Safe Male Circumcision at Uganda's Parliament Health Week
- Making HIV Services More Accessible: MUWRP Refurbishes a Health Centre for the People of Koome Island
- Microbicide Gel Shows Reduced Risk of HIV and Herpes Infection in Women
- Mobile Diagnostic Lab May Help Combat TB and HIV in Tanzania
- Moving Forward this HIV Vaccine Awareness Day
- New Clinical Research Center and Comprehensive Care Center Open in Kericho
- New Cohort Study Begins in Mozambique
- New Cohort Study Begins in Mozambique
- New Data from MHRP Study Impacts Rapid Hepatitis C Test Used on Battlefield
- New Defence Reference Laboratory Commissioned in Nigeria
- New District Youth Center Opens in Uganda
- New Ebola vaccine study begins in Nigeria
- New HIV Counseling and Testing Clinic Opens in Tanzania
- New Insight into Selective Binding Properties of Infectious HIV
- New Journal of Virus Eradication Launches Today
- New Journal of Virus Eradication Launches Today
- New Medical Male Circumcision Program Launched in Uganda
- New Mobile Circumcision Clinic is Officially Launched with a Ribbon Cutting Ceremony
- New Program in Tanzania Aims to Respond to and Reduce Gender Based Violence
- New Report Lauds DoD Overseas Research Laboratories
- New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
- New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
- New Study Aims to Better Understand Hepatitis Infection in Deployed U.S. Forces
- New Study Provides Additional Insights into V2 Antibodies in the RV144 Trial
- New Study Shows a Novel Antibody That Binds to Intracellular Lipids and Inhibits HIV Infection
- New Study, RV306, Begins Screening in Thailand
- New TB Lab Accredited in Tanzania
- New findings provide insight into HIV epidemic in the U.S. Army
- New study highlights need for Hepatitis C screening for U.S. military
- New study shows increase in Kenyan HIV subtypes
- New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
- New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
- Nigeria Unveils 2012 National HIV Vaccine Plan
- OCTANE Study Influences Revision of WHO Guidelines for Treating Some HIV-Infected Women
- PEPFAR Program Representatives Gather in Kenya to Share Successes and Plan for the Future
- PEPFAR Releases Fifth Annual Report to Congress
- PEPFAR's Impact After 10 Years
- Paper published on Phase I/II Study of a Vaccine Candidate in East Africa
- Patients with Advanced HIV and Tuberculosis May Benefit from Starting Antiretroviral Therapy Early
- Phase Ib Ebola/Marburg Vaccine Clinical Trial Begins
- Political Engagement: Tanzania
- Pox-Protein Public-Private Partnership
- Pox-Protein Public-Private Partnership
- President's Bioethics Commmission Released Its Report on Human Subjects Protection
- Presidential Commission for the Study of Bioethical Issues
- Promising Results of Novel Combination HIV Vaccine
- Promising Results of Novel Combination HIV Vaccine
- Prospects for a Globally Effective HIV-1 Vaccine
- Publication Supplements
- RV144 Follow-up Study RV305 Begins in Thailand
- RV144 Update at CROI
- RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
- RV144 Vaccine Regimen Tops Best of Lists in 2009
- RV144: Further Research is Underway
- RV144: The Search for Correlates of Protection Begins
- Researchers Design Global HIV Vaccine that Shows Promise in Early Studies
- Researchers Determine Factors Associated with Elevated Viral Load Setpoint in Sub-Saharan Africa
- Researchers Identify Gene Variant Associated with Protection from HIV in Tanzania
- Researchers Identify New Generic Vaccine Adjuvants
- Researchers Induce HIV-neutralizing Antibodies by Immunization that Recognize both HIV-1 Envelope Protein and Lipids
- Researchers find multiple co-circulating HIV-1 subtypes in North Africa and Middle East
- Risk of Acquiring a Transfusion-Transmitted Infection Found to be Low for Military Personnel Who Receive Blood on the Battlefield
- SAMRMC Wins Research and Development Lab of the Year
- Safe Male Circumcision Services Now Offered at the Mukono Health Center, Uganda
- Senior State Department Leadership Visit Nigeria Sites
- Socioeconomic Impacts of Antiretroviral Therapy and Gender
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- Statement from the Military HIV Research Program on World AIDS Day 2011
- Statement on World AIDS Day 2012
- Study Compares Hospitalization Rates Among HIV Controllers and Those With Medically Controlled HIV in Military Cohort
- Study Finds HIV Vaccine Influences the Genetic Makeup of the Virus
- Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
- Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
- Study finds low ART treatment costs and good retention at clinics in Kenya
- TB and HIV: A Deadly Combinaton
- TB and HIV: A Deadly Combinaton
- Tanzania President Dedicates Mobile Diagnostic Lab
- Tanzanian President Jakaya Kikwete Visits the Walter Reed Army Institute of Research
- Thai Government To Support HIV Vaccine Study
- The Important and Varied Role of Nurses in HIV Research
- The Important and Varied Role of Nurses in HIV Research
- The U.S. and Tanzanian People's Defence Forces Formalize Arrangement to Conduct HIV Care and Treatment Activities in Tanzania
- Time for an HIV Vaccine
- Tragic Loss for The HIV Research Community
- Tragic Loss for The HIV Research Community
- Training for HIV diagnosis and treatment monitoring in Nigeria
- Two New Neutralizing Antibodies Discovered
- U.S. Ambassador to Nigeria Visits Defense Health Club
- U.S. Ambassador to Tanzania Visits MHRP site in Mbeya
- U.S. Army Part of Team to Win HIV Cure Research Grant
- US Army Announces Results of the Landmark RV144 Trial
- US Army Announces Results of the Landmark RV144 Trial
- Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission
- Ugandan Youth Create Murals to Help Promote HIV Prevention
- Update on RV144
- Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys
- Vaccine Partially Protects Monkeys from HIV-like Infection
- Very early seeding of SIV viral reservoir found
- Very early seeding of SIV viral reservoir found
- WRAIR Teams with Sanofi Pasteur to Co-Develop Zika Virus Vaccine
- Walter Reed Army Institute of Research Begins New Phase 2 Clinical Trial of Ebola Vaccine Regimens
- Walter Reed Program - Nigeria Celebrates the Opening of a New Office
- World AIDS Day 2013
- World AIDS Day 2015: The Time to Act is Now
- World AIDS Day Events
- World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
- World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
- World TB Day: MHRP Research Physician Examines Overlap in HIV and Tuberculosis
- World TB Day: MHRP Research Physician Focuses on Problem of TB/HIV Co-infection
- iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
- iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
- Media Room
- Careers
- Contact
© 2020 U.S. Military HIV Research Program | Terms of Use & Disclaimer | Accessibility
- Home
- About Us
- Leadership
- Our Scientists
- Carl Alving, M.D.
- Diane Bolton, Ph.D.
- Michael Eller, Ph.D.
- Gary Matyas, Ph.D.
- Morgane Rolland
- Fred Sawe, MBCHB, MMED
- Rasmi Thomas, Ph.D.
- Sodsai Tovanabutra, M.Sc
- Alexandra Schuetz, Ph.D.
- Alexandra Schuetz, Ph.D.
- M. Gordon Joyce, B.Sc. (Hons), Ph.D.
- Mangala Rao
- Shelly Krebs, Ph.D.
- Victoria Polonis, Ph.D.
- Contributions
- WRAIR
- Partners
- Publications
- Research
- PEPFAR
- Emerging Infections
- International Sites
- News
- Media Room
- Study examins long-term adverse health effects of Ebola survivors
- RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
- Early HIV Infection Study Offers Insight Into the Initial Stages of HIV Infection
- RV144 10th Anniversary
- RV144 10th Anniversary
- Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic In Africa
- Zika Vaccine Development
- MHRP in the News
- Newsletters
- Fact Sheets
- $6.3 M Awarded for the Production of an HIV-1 Subtype C gp145 Env Candidate Vaccine Developed by MHRP Scientists
- 2010 International AIDS Conference, Vienna, Austria
- 2010 International Military HIV/AIDS Conference
- 2010 MHRP World Aids Day Activities
- A Day in the Life of a Nigerian Study Nurse
- A Foucus on Acute Infection Studies
- A Foucus on Acute Infection Studies
- A Trip to Koome Island
- A Vaccine to Prevent Zika Infection in Humans is Feasible
- AFRIMS Celebrates 50 Years of Medical Research In Thailand
- AIDS 2012
- AIDS Vaccine 2012
- AIDS Vaccine Conference 2009
- AIDS Vaccine Researchers Gather in Thailand for Annual Vaccine Conference
- Ambassador Goosby Site Visit
- At the Frontlines of an Epidemic: Combating Ebola in Liberia
- At the Frontlines of an Epidemic: Combating Ebola in Liberia
- Bioethics Commission Urges US to Adopt Ethical Approach to Ebola & Health Preparedness
- Biomarkers of Disease Progression Appear to Differ in Sub-Saharan Population
- Bringing Health Services to the People
- Bringing Health Services to the People
- Building on RV144: HIV Vaccien Trial Launches in South Africa
- COL Kim Provides Commentary for Series, "30 years in 30 weeks"
- CROI 2012 Wrap Up
- CROI 2013 Wrap-up
- Capt. Darrell Singer Recognized for His Exceptional Contributions to PEPFAR
- Caring for the Children Left Behind by HIV
- Clinical center expands and enhances care in Mbeya, Tanzania
- Collaborative Efforts to Combat Malaria in Tanzania
- Community Events Promote HIV Vaccine Awareness in Kenya
- Community Relations: Uganda Participates in Kampala Marathon
- Community and Media Events Promote Vaccine Importance in Uganda
- Comprehensive New Framework to Speed and Enhance HIV Research
- Congressional Delegation Visits MHRP Site in Kericho, Kenya
- Contraception Use During HIV Vaccine Trial
- DoD Leadership Visits MHRP's Nigeria Research Site
- Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
- Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
- Duke and MHRP Win Award for Best Academic Research Team
- Early Infant Diagnosis and Rapid Treatment Key to Meeting UNAIDS 90-90-90 Targets
- Early Study Shows MHRP Vaccine Candidate, MVA-CMDR, Safe and Immunogenic
- Early antiretroviral therapy dramatically reduces HIV DNA set point
- Early-Capture HIV Study Allows for Characterization of Acute Infection Period
- Family day at an HIV clinic in Tanzania
- Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
- Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
- HIV Vaccine Awareness Day 2019
- MHRP Researcher Dr. Morgane Rolland on the Importance of Viral Genetics
- MHRP Scientists and Collaborators Presenting at CROI 2019
- MHRP Scientists and Collaborators Presenting at IAS 2019
- MHRP Scientists and Collaborators Presenting at Keystone Symposia 2019
- MHRP's Top Highlights of 2019
- New Sequencing Study Provides Insight into HIV Vaccine Protection
- New study reveals how specialized antimicrobial human T cells responds in acute HIV infection
- Three Neutralizing Antibody Lineages Identified from an HIV-1-Infected Individual
- US Army and partners to launch HIV vaccine efficacy trial in the Americas and Europe
- World AIDS Day Event Highlights DoD Contributions to Fight the HIV Pandemic
- ‘This Is What It Means to Be Empowered’
- Announcing Dr. Sandhya Vasan as MHRP's Associate Director for HIV Vaccine Research
- Army-developed Zika Vaccine Induces Strong Immune Response in Three Phase 1 Studies
- Biomarker Signatures in Acute HIV Infection Associate with ViralDynamics and Reservoir Size
- Characterization of T Cells Infected with Simian Immunodeficiency Virus Reveals Host-pathogen Interactions
- DREAMS Work in Mbeya Provides a Path Out of Prostitution
- Dr. Robert Gramzinski Named as New Director of MHRP
- Experimental Vaccine Blocks Effects of Heroin in Mice
- HIV Viral Load Rebounds Rapidly After Treatment Interruption in Individuals Who Begin ART During Fiebig I
- Landmark Acute HIV Infection Cohort Study Concludes
- MHRP Scientists and Collaborators Presenting at AIDS 2018
- MHRP Scientists and Collaborators Presenting at CROI 2018
- MHRP Scientists and Collaborators at the ASTMH Annual Meeting
- MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2018
- MHRP at the 2018 Military Health System Research Symposium
- Navigating the Path to an HIV Vaccine
- New HIV Cohort Study Opens In Germany
- RNA Signatures of Natural Killer Immune Cells Suggest Increased Activity Following HIV Vaccination
- Social Science Research Involving MHRP Acute HIV Infection Cohort Seeks to Understand Volunteers' Perspectives in Treatment Interruption Studies
- Study Links Gut-Homing Protein Levels With HIV Infection Risk, Disease Progression
- Study of Severe Infectious Diseases Enrolls 100th Volunteers
- World AIDS Day 2017
- World AIDS Day 2018
- Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa
- Col. Nelson Michael Selected as One of Vice Motherboard’s ‘Humans of the Year’
- Diagnosis of Acute HIV Infection and Immediate Treatment Reduces Transmission by 89% in Thai Cohort
- Dr. Carl Alving Inducted as National Academy of Inventors Fellow
- Dr. Lydie Trautmann Awarded R01 Grant from National Institute of Mental Health
- Dual-use Heroin Vaccine Elicits Immune Response in Mice
- Experts identify challenges to fast-track development of Zika vaccine
- First Public Meeting of Cross-Sector HIV Cure Project
- Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine
- Initiating ART During Acute HIV Infection Affects Trajectory of Viral Load
- Insight into Acute HIV Infection
- Investigational HIV Therapeutic Vaccine Approach Helps Control SIV in Preclinical Studies
- Joint West Africa Research Group Begins Infectious Disease Surveillance Study in Nigeria
- Koome Island Demonstration Farm Helps Support Women and Families
- Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial
- MHRP Researchers and Collaborators Presenting at CROI 2017
- MHRP Welcomes Dr. M. Gordon Joyce, Chief of New Structural Biology Lab Section
- MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2016
- MHRP and Collaborators at the 9th IAS Conference on HIV Science
- MHRP scientists and collaborators detect declining trend in transmitted drug resistance in acute HIV infection cohort
- New MHRP PEPFAR-funded study to examine malaria and TB HIV co-infection in Kenyan Defence Forces
- New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
- New Study Provides Clues to Early T Cell Immune Responses in Acute HIV Infection
- Nigeria Biopreparedness Initiative Launches with Laboratory Training and Site Assessment
- Nigeria Study Identifies Potential Cohorts for HIV Vaccine Development
- U.S. Officials Visit with Participants in DREAMS Program
- World AIDS Day 2016: Reinvigorating the Field
- First-in-Human Phase 1 Clinical Trial of MERS Vaccine Begins
- Fitness training and events help increase HIV prevention awareness in Kenya
- Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
- Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
- Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
- Future of HIV Cure Research Points to Combination Approach
- HIV Infant Tracking System (HITSystem) Improves Early Infant Diagnosis Outcomes for HIV-Exposed Infants in Tanzania
- HIV Prevention, Care and Treatment Open House Draws Thousands to Tanzania's Southern Highlands
- HIV Vaccine Awareness Day 2009
- HIV Vaccine Awareness Day 2010
- HIV Vaccine Awareness Day 2011
- HIV Vaccine Awareness Day 2011 Activities
- HIV Vaccine Awareness Day: Building on the Success of RV144
- HIV Vaccine Development and the US Military
- HIV Vaccine Development and the US Military
- HIV Vaccine Research Center of Excellence to Open at AFRIMS
- HIV-1 Immune Evasion Mutations Could Impact Future Vaccine Efficacy
- How the Military is Engaged in the Battle Against Malaria
- How the Military is Engaged in the Battle Against Malaria
- Human Clinical Trial of DNA-MVA HIV Vaccine Candidate Begins
- Human Clinical Trial of a New DNA-MVA Vaccine Candidate Begins in Africa
- Human Genetic Studies Underscore Similarities Among East African Populations
- Humanized DRAG Mouse Model Holds Promise For Pre-Clinical Testing of Candidate HIV Vaccines
- IRIS Study Opens in Kericho, Kenya
- Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya
- In Memory of Sen. Daniel K. Inouye
- In Memory of our Nigerian Colleagues
- In South Africa, RV144 HIV Vaccine Regimen Induces Immune Responses Similiar to Those Seen in Thailand
- In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
- In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
- Infection with Multiple HIV-1 Variants Leads to Poorer Clinical Outcomes
- Initiation of ART during Acute HIV Infection Leads to High Rate of Non-Reactive HIV Serology
- Innovative "Moonlight" HIV Counseling and Testing
- Interview with Ambassador Goosby, U.S. Global AIDS Coordinator
- Joint West Africa Research Group to Foster Biopreparedness
- Joint West Africa research Group Completes First Training in Nigeria
- Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
- Laboratory Training Program Brings Together MHRP, Nigerian Military and the U.S. Public Health Service
- Lancet Article Explores Efficacy Variables in RV144
- Large Multinational HIV Cohort Study Begins in Africa
- Long-term Adverse Health Effects of Ebola Survivors Examined in New Lancet ID Paper
- MHRP Collaborates with Maryland's Institute of Human Virology on Promising HIV/AIDS Vaccine Candidate
- MHRP Community Engagement Meeting held in Uganda
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Congratulates COL Jerome Kim on Top IVI Appointment
- MHRP Deputy Col. Jerome Kim Receives Award for Research Excellence
- MHRP Diagnostics: A Unique Capability within the DoD
- MHRP Diagnostics: A Unique Capability within the DoD
- MHRP Director receives the Hero of Military Medicine Award for the U.S. Army
- MHRP Kenya Country Director Receives Prestigious Military Civilian Award
- MHRP Launches New Quarterly Newsletter
- MHRP Leadership Meets with the President of Tanzania
- MHRP Marks HIV Vaccine Awareness Day
- MHRP Named a Clinical Trials Unit for NIH HIV/AIDS Clinical Trials Networks
- MHRP Partners with Tanzanian People's Defense Forces to Open HIV Counseling and Testing Center
- MHRP Profiles
- MHRP Profiles
- MHRP Profiles: Ebola Vaccine Trial Participant
- MHRP Researcher Receives HIV Prevention Research Advocacy Fellowship
- MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
- MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
- MHRP Researchers find Host Genetics Played a Role in RV144 Protection
- MHRP Researchers find Host Genetics Played a Role in RV144 Protection
- MHRP Scientist Discusses WHO Ebola Collaboration
- MHRP Scientist Wins 2012 NIDA Avant-Garde Award for Combination Anti-Heroin/HIV Vaccine
- MHRP Scientists Take Part in AIDS Vaccine 2010 Conference in Atlanta
- MHRP Scientists and Collaborators Presenting at AIDS 2016
- MHRP Scientists and Collaborators Presenting at CROI 2016
- MHRP Welcomes Dr. Hendrik Streeck
- MHRP Welcomes Dr. Jintanat Ananworanich as Associate Director for Therapeutics Research
- MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
- MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
- MHRP and Collaborators Presenting at Keystone Symposia HIV Vaccine and HIV Persistence Meetings
- MHRP and Colleagues Featured in Special JAIDS Supplement
- MHRP at AIDS Vaccine 2013
- MHRP at CROI 2014
- MHRP at CROI 2014
- MHRP at HIV Research for Prevenetion (R4P) 2014
- MHRP at HIV Research for Prevenetion (R4P) 2014
- MHRP in the News: September 2011
- MHRP selected by the AIDS Clinical Trials Group (ACTG) as a Clinical Trials Unit
- MHRP's Administrative Offices Have Moved
- MUWRP Celebrates Ten Years of Progress
- MUWRP Provides Safe Male Circumcision at Uganda's Parliament Health Week
- Making HIV Services More Accessible: MUWRP Refurbishes a Health Centre for the People of Koome Island
- Microbicide Gel Shows Reduced Risk of HIV and Herpes Infection in Women
- Mobile Diagnostic Lab May Help Combat TB and HIV in Tanzania
- Moving Forward this HIV Vaccine Awareness Day
- New Clinical Research Center and Comprehensive Care Center Open in Kericho
- New Cohort Study Begins in Mozambique
- New Cohort Study Begins in Mozambique
- New Data from MHRP Study Impacts Rapid Hepatitis C Test Used on Battlefield
- New Defence Reference Laboratory Commissioned in Nigeria
- New District Youth Center Opens in Uganda
- New Ebola vaccine study begins in Nigeria
- New HIV Counseling and Testing Clinic Opens in Tanzania
- New Insight into Selective Binding Properties of Infectious HIV
- New Journal of Virus Eradication Launches Today
- New Journal of Virus Eradication Launches Today
- New Medical Male Circumcision Program Launched in Uganda
- New Mobile Circumcision Clinic is Officially Launched with a Ribbon Cutting Ceremony
- New Program in Tanzania Aims to Respond to and Reduce Gender Based Violence
- New Report Lauds DoD Overseas Research Laboratories
- New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
- New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
- New Study Aims to Better Understand Hepatitis Infection in Deployed U.S. Forces
- New Study Provides Additional Insights into V2 Antibodies in the RV144 Trial
- New Study Shows a Novel Antibody That Binds to Intracellular Lipids and Inhibits HIV Infection
- New Study, RV306, Begins Screening in Thailand
- New TB Lab Accredited in Tanzania
- New findings provide insight into HIV epidemic in the U.S. Army
- New study highlights need for Hepatitis C screening for U.S. military
- New study shows increase in Kenyan HIV subtypes
- New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
- New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
- Nigeria Unveils 2012 National HIV Vaccine Plan
- OCTANE Study Influences Revision of WHO Guidelines for Treating Some HIV-Infected Women
- PEPFAR Program Representatives Gather in Kenya to Share Successes and Plan for the Future
- PEPFAR Releases Fifth Annual Report to Congress
- PEPFAR's Impact After 10 Years
- Paper published on Phase I/II Study of a Vaccine Candidate in East Africa
- Patients with Advanced HIV and Tuberculosis May Benefit from Starting Antiretroviral Therapy Early
- Phase Ib Ebola/Marburg Vaccine Clinical Trial Begins
- Political Engagement: Tanzania
- Pox-Protein Public-Private Partnership
- Pox-Protein Public-Private Partnership
- President's Bioethics Commmission Released Its Report on Human Subjects Protection
- Presidential Commission for the Study of Bioethical Issues
- Promising Results of Novel Combination HIV Vaccine
- Promising Results of Novel Combination HIV Vaccine
- Prospects for a Globally Effective HIV-1 Vaccine
- Publication Supplements
- RV144 Follow-up Study RV305 Begins in Thailand
- RV144 Update at CROI
- RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
- RV144 Vaccine Regimen Tops Best of Lists in 2009
- RV144: Further Research is Underway
- RV144: The Search for Correlates of Protection Begins
- Researchers Design Global HIV Vaccine that Shows Promise in Early Studies
- Researchers Determine Factors Associated with Elevated Viral Load Setpoint in Sub-Saharan Africa
- Researchers Identify Gene Variant Associated with Protection from HIV in Tanzania
- Researchers Identify New Generic Vaccine Adjuvants
- Researchers Induce HIV-neutralizing Antibodies by Immunization that Recognize both HIV-1 Envelope Protein and Lipids
- Researchers find multiple co-circulating HIV-1 subtypes in North Africa and Middle East
- Risk of Acquiring a Transfusion-Transmitted Infection Found to be Low for Military Personnel Who Receive Blood on the Battlefield
- SAMRMC Wins Research and Development Lab of the Year
- Safe Male Circumcision Services Now Offered at the Mukono Health Center, Uganda
- Senior State Department Leadership Visit Nigeria Sites
- Socioeconomic Impacts of Antiretroviral Therapy and Gender
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
- Statement from the Military HIV Research Program on World AIDS Day 2011
- Statement on World AIDS Day 2012
- Study Compares Hospitalization Rates Among HIV Controllers and Those With Medically Controlled HIV in Military Cohort
- Study Finds HIV Vaccine Influences the Genetic Makeup of the Virus
- Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
- Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
- Study finds low ART treatment costs and good retention at clinics in Kenya
- TB and HIV: A Deadly Combinaton
- TB and HIV: A Deadly Combinaton
- Tanzania President Dedicates Mobile Diagnostic Lab
- Tanzanian President Jakaya Kikwete Visits the Walter Reed Army Institute of Research
- Thai Government To Support HIV Vaccine Study
- The Important and Varied Role of Nurses in HIV Research
- The Important and Varied Role of Nurses in HIV Research
- The U.S. and Tanzanian People's Defence Forces Formalize Arrangement to Conduct HIV Care and Treatment Activities in Tanzania
- Time for an HIV Vaccine
- Tragic Loss for The HIV Research Community
- Tragic Loss for The HIV Research Community
- Training for HIV diagnosis and treatment monitoring in Nigeria
- Two New Neutralizing Antibodies Discovered
- U.S. Ambassador to Nigeria Visits Defense Health Club
- U.S. Ambassador to Tanzania Visits MHRP site in Mbeya
- U.S. Army Part of Team to Win HIV Cure Research Grant
- US Army Announces Results of the Landmark RV144 Trial
- US Army Announces Results of the Landmark RV144 Trial
- Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission
- Ugandan Youth Create Murals to Help Promote HIV Prevention
- Update on RV144
- Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys
- Vaccine Partially Protects Monkeys from HIV-like Infection
- Very early seeding of SIV viral reservoir found
- Very early seeding of SIV viral reservoir found
- WRAIR Teams with Sanofi Pasteur to Co-Develop Zika Virus Vaccine
- Walter Reed Army Institute of Research Begins New Phase 2 Clinical Trial of Ebola Vaccine Regimens
- Walter Reed Program - Nigeria Celebrates the Opening of a New Office
- World AIDS Day 2013
- World AIDS Day 2015: The Time to Act is Now
- World AIDS Day Events
- World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
- World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
- World TB Day: MHRP Research Physician Examines Overlap in HIV and Tuberculosis
- World TB Day: MHRP Research Physician Focuses on Problem of TB/HIV Co-infection
- iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
- iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
- Media Room
- Careers
- Contact